Finzati - Logo
ACET logo

Adicet Bio, Inc.

ACET • Biotechnology
$4.52
▼ -0.01 (-0.22%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$49.54M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 93.5%Manageable debt level · 0.09Healthy liquidity · 7.47Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:43 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$4.52
Change-0.22%
Shares Out10.75M
Market Cap$49.54M
Enterprise Value$-68.65M
52W Range6.01 - 17.44
Beta1.59
P/E-0.50
P/B0.41
P/FCF-0.47
EV/EBITDA0.74
EV/FCF0.64

Investment DNA

How strong this company looks for long-term investors

56
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Positive revenue growth · 93.5%Manageable debt level · 0.09Healthy liquidity · 7.47Weak profitability

Analyst view

Analyst sentiment and price target

ACET
Analyst sentiment
Based on 12 analyst votes · 2026-10-20
88/100
Bullish
Bullish
9
Hold
3
Bearish
0
Price Target
2026-08-07
Low
$18.00
Mean
$352.67
Median
$432.00
High
$608.00

Company Overview

IPO: 1/26/2018
Industry: Biotechnology
P/B i: 0.41
Debt / Equity i: 0.09
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.09
Current Ratio: 7.47
Quick Ratio: 7.47
Status: Good

Insider Transactions

Recent executive and insider activity

⚠ 1 high-volume insider sell detected
Klickstein Lloyd
Transaction: 06/21/2026
BUY
Change
+4,200
Price
$8.10
Filing
06/23/2026
Type
BUY
Peng Katie
Transaction: 06/21/2026
BUY
Change
+4,200
Price
$8.10
Filing
06/23/2026
Type
BUY
Sinclair Andrew
Transaction: 06/21/2026
BUY
Change
+4,200
Price
$8.10
Filing
06/23/2026
Type
BUY